Markets
News
Analysis
Tools
Learn
Features
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Sign Up
Markets
/
Stocks
/
nasdaq-rgc
/
Regencell Bioscience Holdings Ltd
RGC
12.280
USD
-0.520
-4.06%
Close 08/25, 16:00(ET)
Quotes delayed by 15 min
0.000
USD
0.000
Pre-market 08/26, 09:30 (ET)
6.07B
Market Cap
--
P/E TTM
Regencell Bioscience Holdings Ltd
12.280
-0.520
-4.06%
Overview
Company
Financials
Statements
Income Statement
Balance Sheet
Cash Flow Statement
Overview
Company
Financials
Statements
Income Statement
Balance Sheet
Cash Flow Statement
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025H1
FY2024H2
FY2024H1
FY2023H2
FY2023H1
FY2022H2
FY2022H1
FY2021Q4
FY2021Q2
Total equity
Cash, cash equivalents and short-term investments
--
--
-31.16%
7.96M
--
--
-29.56%
11.56M
--
--
--
16.42M
--
--
--
59.41K
--
305.96K
- Cash and cash equivalents
--
--
89.24%
2.96M
--
--
-75.61%
1.56M
--
--
--
6.42M
--
--
--
59.41K
--
305.96K
-Short-term investments
--
--
-50.00%
5.00M
--
--
0.00%
10.00M
--
--
--
10.00M
--
--
--
--
--
--
Prepaid expenses
--
--
170.17%
152.78K
--
--
104.90%
56.55K
--
--
--
27.60K
--
--
--
7.44K
--
--
Total current assets
-33.02%
6.59M
-30.18%
8.11M
-30.72%
9.83M
-29.33%
11.62M
-25.35%
14.19M
--
16.44M
--
19.01M
--
66.85K
--
305.96K
Non-current assets
Net Fixed Assets
--
--
-74.60%
226.51K
--
--
-38.91%
891.91K
--
--
--
1.46M
--
--
--
81.86K
--
110.26K
-Fixed Assets
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
117.84K
--
133.11K
-Accumulated depreciation
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
35.97K
--
22.85K
Other non-current assets
--
--
-9.97%
97.68K
--
--
-5.08%
108.50K
--
--
--
114.30K
--
--
--
191.42K
--
184.16K
Total non-current assets
38.96%
892.74K
-67.59%
324.20K
-52.62%
642.42K
-36.45%
1.00M
-33.91%
1.36M
--
1.57M
--
2.05M
--
273.29K
--
294.42K
Total assets
-28.60%
7.48M
-33.15%
8.44M
-32.63%
10.48M
-29.95%
12.62M
-26.18%
15.55M
--
18.02M
--
21.06M
--
340.13K
--
600.37K
Liabilities
Current liabilities
-Other payables
--
--
-20.12%
8.44K
--
--
-32.46%
10.57K
--
--
--
15.65K
--
--
--
3.33M
--
--
Accrued expenses
--
--
-20.72%
125.33K
--
--
4.60%
158.08K
--
--
--
151.13K
--
--
--
572.99K
--
42.13K
Short-term debt and lease liabilities
--
--
--
--
--
--
--
--
--
--
--
0.00
--
--
--
431.97K
--
3.54M
-Short-term debt
--
--
--
--
--
--
--
--
--
--
--
0.00
--
--
--
431.97K
--
3.54M
Other current liabilities
--
--
-20.12%
8.44K
--
--
-32.46%
10.57K
--
--
--
15.65K
--
--
--
3.33M
--
--
Total current liabilities
--
--
-68.10%
193.58K
--
--
5.05%
606.91K
--
--
--
577.76K
--
--
--
4.34M
--
3.59M
Non-current liabilities
Long-term debt and lease liabilities
--
0.00
2.08%
25.93K
--
0.00
-92.95%
25.41K
--
0.00
--
360.27K
--
0.00
--
0.00
--
0.00
-Long-term lease liabilities
--
--
2.08%
25.93K
--
--
-92.95%
25.41K
--
--
--
360.27K
--
--
--
--
--
--
Total non-current liabilities
--
--
2.08%
25.93K
--
--
-92.95%
25.41K
--
--
--
360.27K
--
--
--
--
--
--
Total liabilities
144.39%
763.84K
-65.28%
219.51K
-64.23%
312.55K
-32.59%
632.32K
-35.93%
873.79K
--
938.03K
--
1.36M
--
4.34M
--
3.59M
Shareholders' equity
Common equity
--
--
1.53%
29.88M
--
--
3.24%
29.43M
--
--
--
28.51M
--
--
--
356.00
--
356.00
Retained earnings
--
--
-24.84%
-21.62M
--
--
-51.30%
-17.32M
--
--
--
-11.44M
--
--
--
-4.00M
--
-2.99M
Capital reserves
--
--
1.53%
29.88M
--
--
3.24%
29.43M
--
--
--
28.51M
--
--
--
256.00
--
256.00
Gains losses not affecting retained earnings
--
--
47.19%
-45.77K
--
--
--
-86.66K
--
--
--
--
--
--
--
--
--
--
Non-controlling interests
--
--
100.00%
0.00
--
--
-365.78%
-40.90K
--
--
--
15.39K
--
--
--
--
--
--
Total equity
-33.92%
6.72M
-31.45%
8.22M
-30.75%
10.16M
-29.81%
11.99M
-25.51%
14.67M
--
17.08M
--
19.70M
--
-4.00M
--
-2.98M
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
KeyAI
Please log in to use KeyAI
Log in
Sign Up